Poly(DL -lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices

Journal of Biomedical Materials Research - Part A

Volumn 98 A, Issue 1, 2011, Pages 80-87

  Sharkawi, Tahmer ^a   Darcos, Vincent ^b   Vert, Michel ^b  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

bioresorbable; cardiovascular medical device; hemocompatibility; heparin immobilization; platelet adhesion; poly(lactic acid); surface modification

Indexed keywords

BIORESORBABLE; HEMOCOMPATIBILITY; HEPARIN IMMOBILIZATION; MEDICAL DEVICES; PLATELET ADHESION; POLY(LACTIC ACID);

ADHESION; AMINATION; ANGLE MEASUREMENT; BIOMEDICAL ENGINEERING; BODY FLUIDS; CONTACT ANGLE; LACTIC ACID; PLATELETS; TRITIUM;

POLYSACCHARIDES;

CARBOXYL GROUP; HEPARIN; N HYDROXYSUCCINIMIDE; POLYLACTIC ACID; TRITIUM;

ANTICOAGULATION; ARTICLE; CHEMICAL MODIFICATION; CONTACT ANGLE; HEPARINIZATION; HUMAN; HUMAN CELL; RADIOACTIVITY; THROMBOCYTE ADHESION; THROMBOCYTE STRUCTURE; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CHROMATOGRAPHY, GEL; ELEMENTS; FACTOR XA; HEPARIN; HUMANS; LACTIC ACID; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; PHOTOELECTRON SPECTROSCOPY; PLATELET ADHESIVENESS; PLATELET COUNT; POLYMERS; STAINING AND LABELING; SURFACE PROPERTIES; SUS SCROFA; WATER;

EID: 79958190828     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33099     Document Type: Article

References (20)

1. Dumitriu S,. Polymeric Biomaterials, 2nd ed. New York: Marcel Dekker; 2002.
2. Meddahi-Pellé A, Bataille I, Subra P, Letourneur D,. Vascular biomaterials: From biomedical engineering to tissue engineering. Med Sci 2004; 20: 679-684. (Pubitemid 38917719)
3. Lafont A, Li SM, Garreau H, Cornhill F, Vert M,. PLA stereocopolymers as source of bioresorbable stents: Preliminary investigation. J Biomed Mater Res 2006; 77B: 349-356. (Pubitemid 43667458)
4. Vert M,. Poly(lactic acid)s. In:, Doi Y, editor. Encyclopedia of Biomaterials and Biomedical Engineering. New York: Marcel Dekker; 2004. p 1254-1263.
5. Tanzi MC,. Bioactive technologies for hemocompatibility. Exp Rev Med Dev 2005; 2: 473-492. (Pubitemid 41015129)
6. Conn G, Kidane AG, Punshon G, Kannan RY, Hamilton G, Seifalian AM,. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? Exp Rev Med Dev 2006; 3: 245-261.
7. Chupa JM, Foster AM, Sumner SR, Madihally SV, Matthew HWT,. Vascular cell responses to polysaccharide materials: In vitro and in vivo evaluations. Biomaterials 2000; 21: 2315-2322.
8. Letourneur D, Machy D, Pellé A, Marcon-Bachari E, D'Angelo G, Vogel M, Chaubet F, Michel JB. Heparin and non heparin like dextrans differentially modulate endothelial cell proliferation: In vitro evaluation with soluble and crosslinked polysaccharide matrices. J Biomed Mater Res 2002; 60: 94-100. (Pubitemid 34126990)
9. Lin Q, Yan J, Qiu F, Song X, Fu G, Ji J,. Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent. J Biomed Mater Res A 2011; 96: 132-141.
10. Yang Z, Wang J, Luo R, Maitz MF, Jing F, Sun H, Huang N,. The covalent immobilization of heparin to pulsed-plasma polymeric allylamine films on 316L stainless steel and the resulting effects on hemocompatibility. Biomaterials 2010; 31: 2072-2083.
11. Zhu A, Zhang M, Wu J, Shen J,. Covalent immobilization of chitosan/heparin complexe with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials 2002; 23: 4657-4665. (Pubitemid 36151618)
12. Meng B, Wang XH, Cui FZ, Dong HY, Yu FJ,. A new method of heparinizating PLLA film by surface entrapment. Bioact Compat Polym 2004; 19: 131-143. (Pubitemid 38560191)
13. Seifert B, Groth TH, Herrmann K, Romaniuk PJ,. Immobilization of heparin on polylactide for application to degradable biomaterials in contact with blood. J Biomater Sci Polym Ed 1995; 7: 277-287.
14. Zhu YB, Gao CY, He T, Liu XY, Shen JC,. Layer by layer assembly to modify poly(L -lactic acid) surface toward improving its cytocompatibility to human endothelial cells. Biomacromolecules 2003; 4: 446-452. (Pubitemid 36527119)
15. Croll TI, AJ OC, Stevens GW, Cooper White JJ,. Controllable surface modification of poly(lactic-co-glycolic) acid (PLGA) by hydrolysis or aminolysis 1: Physical, chemical and theoretical aspects. Biomacromolecules 2004; 5: 463-473. (Pubitemid 38404482)
16. Schwach G, Coudane J, Engel R, Vert M,. Ring opening polymerization of D, L -lactide in the presence of zinc metal and zinc lactate. Polym Int 1998; 46: 177-182. (Pubitemid 128494631)
17. United States Pharmacopoeial Convention, 28th ed. Heparin Sodium official monograph, In USP28-NF23, Rockville; 2005. p 941-942.
18. Rabenstein DL,. Heparin and heparin sulphate: Structure and function. Nat Prod Rep 2002; 19: 312-331.
19. Jin L, Abrahams JP, Skinner R, Petitou M, Pike R, Carrell R,. The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci USA 1997; 94: 14683-14688. (Pubitemid 28041434)
20. Diancourt F, Braud C, Vert M,. Chemical modifications of heparin 1: Reaction of partially N-desulphated heparin with glutareldehyde. J Bioact Compat Polym 1994; 9: 267-281. (Pubitemid 24310329)